Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 17848840)

1.
2.

Polymorphic basal rates of continuous subcutaneous insulin infusion among Taiwanese children with type 1 diabetes.

Lin CH, Hsieh FJ, Van YH, Lo FS.

Biomed Res Int. 2015;2015:250656. doi: 10.1155/2015/250656. Epub 2015 Jan 31.

3.

Relationship between Basal insulin requirement and body mass index in children and adults with type 1 diabetes on insulin pump therapy.

Deeb A, Abu-Awad S, Tomy M, Suliman S, Mustafa H.

J Diabetes Sci Technol. 2015 May;9(3):711-2. doi: 10.1177/1932296815572681. Epub 2015 Feb 17. No abstract available.

PMID:
25691654
4.

A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosis.

Gallagher BR, Mahony OM, Rozanski EA, Buob S, Freeman LM.

J Vet Emerg Crit Care (San Antonio). 2015 Mar-Apr;25(2):234-9. doi: 10.1111/vec.12269. Epub 2014 Dec 24.

PMID:
25546713
5.

Carbohydrate-to-Insulin Ratio in a Mediterranean Population of Type 1 Diabetic Patients on Continuous Subcutaneous Insulin Infusion Therapy.

Alcántara-Aragón V, Gonzalez C, Corcoy R, Ubeda J, Chico A.

J Diabetes Sci Technol. 2015 May;9(3):588-92. doi: 10.1177/1932296814563571. Epub 2014 Dec 17.

PMID:
25519294
6.
7.

Authors' reply to Dr. Malerbi: "Insulin glargine in a Brazilian state: should the government disinvest?".

de Souza AL, Acurcio Fde A, Guerra Júnior AA, do Nascimento RC, Godman B, Diniz LM.

Appl Health Econ Health Policy. 2014 Oct;12(5):561-3. doi: 10.1007/s40258-014-0113-x. No abstract available.

PMID:
25119850
8.

Comment on: "Insulin glargine in a Brazilian state: should the government disinvest?".

Malerbi DA.

Appl Health Econ Health Policy. 2014 Oct;12(5):559-60. doi: 10.1007/s40258-014-0111-z. No abstract available.

PMID:
25119849
9.

Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.

Olsen B, Johannesen J, Fredheim S, Svensson J; Danish Society for Childhood and Adolescent Diabetes.

Pediatr Diabetes. 2015 Jun;16(4):256-62. doi: 10.1111/pedi.12164. Epub 2014 Jul 31.

PMID:
25082292
10.

Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment.

Joubert M, Morera J, Vicente A, Rod A, Parienti JJ, Reznik Y.

J Diabetes Sci Technol. 2014 Sep;8(5):1005-10. doi: 10.1177/1932296814537040. Epub 2014 May 27.

PMID:
24876454
11.

Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.

Talaviya PA, Saboo BD, Joshi SR, Padhiyar JN, Chandarana HK, Shah SJ, Vyas CK, Shah AN.

Diabetes Metab Syndr. 2013 Apr-Jun;7(2):68-71. doi: 10.1016/j.dsx.2013.02.032. Epub 2013 Mar 30.

PMID:
23680243
12.

Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.

Cohen ND, Hong ES, Van Drie C, Balkau B, Shaw J.

Diabetes Technol Ther. 2013 Jul;15(7):544-9. doi: 10.1089/dia.2012.0331. Epub 2013 Apr 25.

PMID:
23617252
13.

Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.

Levy-Shraga Y, Lerner-Geva L, Modan-Moses D, Graph-Barel C, Mazor-Aronovitch K, Boyko V, Pinhas-Hamiel O.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):225-9. doi: 10.1055/s-0032-1331698. Epub 2013 Jan 17.

PMID:
23329580
14.
15.

Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus.

Batajoo RJ, Messina CR, Wilson TA.

J Clin Res Pediatr Endocrinol. 2012 Sep;4(3):127-31. doi: 10.4274/Jcrpe.751.

16.
17.

Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections.

Leinung MC, Thompson S, Luo M, Leykina L, Nardacci E.

Endocr Pract. 2013 Jan-Feb;19(1):9-13. doi: 10.4158/EP12104.OR.

PMID:
22982794
18.

[Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].

Hasselmann C, Bonnemaison E, Faure N, Mercat I, Bouillo Pépin-Donat M, Magontier N, Chantepie A, Labarthe F.

Arch Pediatr. 2012 Jun;19(6):593-8. doi: 10.1016/j.arcped.2012.03.051. Epub 2012 May 14. French.

PMID:
22584198
19.

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.

Kaiserman K, Rodriguez H, Stephenson A, Wolka L, Fahrbach JL.

Endocr Pract. 2012 May-Jun;18(3):418-24. doi: 10.4158/EP11265.RA. Review.

PMID:
22297055
20.

Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?

Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M.

Diabetes Technol Ther. 2012 May;14(5):389-97. doi: 10.1089/dia.2011.0267. Epub 2012 Jan 27.

PMID:
22283639
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk